DOI QR코드

DOI QR Code

The predictive value of echocardiography for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism in Korea

  • Park, Jin Sup (Division of Cardiology, Medical Research Institute, Department of Internal Medicine, Pusan National University Hospital) ;
  • Ahn, Jinhee (Division of Cardiology, Medical Research Institute, Department of Internal Medicine, Pusan National University Hospital) ;
  • Choi, Jung Hyun (Division of Cardiology, Medical Research Institute, Department of Internal Medicine, Pusan National University Hospital) ;
  • Lee, Hye Won (Division of Cardiology, Medical Research Institute, Department of Internal Medicine, Pusan National University Hospital) ;
  • Oh, Jun-Hyok (Division of Cardiology, Medical Research Institute, Department of Internal Medicine, Pusan National University Hospital) ;
  • Lee, Han Cheol (Division of Cardiology, Medical Research Institute, Department of Internal Medicine, Pusan National University Hospital) ;
  • Cha, Kwang Soo (Division of Cardiology, Medical Research Institute, Department of Internal Medicine, Pusan National University Hospital) ;
  • Hong, Taek Jong (Division of Cardiology, Medical Research Institute, Department of Internal Medicine, Pusan National University Hospital)
  • Received : 2014.06.16
  • Accepted : 2015.03.23
  • Published : 2017.01.01

Abstract

Background/Aims: Chronic thromboembolic pulmonary hypertension (CTEPH) is a life-threatening complication after acute pulmonary embolism (APE) and is associated with substantial morbidity and mortality. This study aimed to investigate the incidence of CTEPH after APE in Korea and to determine echocardiographic predictors of CTEPH. Methods: Among 381 patients with APE confirmed by chest computed tomography (CT) between January 2007 and July 2013, 246 consecutive patients with available echocardiographic data were enrolled in this study. CTEPH was defined as a persistent right ventricular systolic pressure (RVSP) greater than 35 mmHg on echocardiography during follow-up and persistent pulmonary embolism on the follow-up CT. Results: Fifteen patients (6.1%) had CTEPH. The rate of right ventricular (RV) dilatation (66.7% vs. 28.1%, p = 0.002) and the RVSP (75.5 mmHg vs. 39.0 mmHg, p < 0.001) were significantly higher in the CTEPH group. D-dimers, RV dilatation, RV hypertrophy, RVSP, and intermediate-risk APE were associated with the risk of CTEPH after APE (odds ratio [OR] 0.59, 5.11, 7.82, 1.06, and 4.86, respectively) on univariate analysis. RVSP remained as a significant predictor of CTEPH on multivariate analysis (OR, 1.056; 95% confidence interval, 1.006 to 1.109; p = 0.029). Conclusions: This study showed that the incidence of CTEPH after APE in Korea was 6.1% and that initial RVSP by echocardiography was a strong prognostic factor for CTEPH.

Keywords

Acknowledgement

Supported by : Pusan National University

References

  1. Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 2001;119:818-823. https://doi.org/10.1378/chest.119.3.818
  2. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006;113:2011-2020. https://doi.org/10.1161/CIRCULATIONAHA.105.602565
  3. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-2264. https://doi.org/10.1056/NEJMoa032274
  4. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537. https://doi.org/10.1093/eurheartj/ehp297
  5. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713. https://doi.org/10.1016/j.echo.2010.05.010
  6. McConnell MV, Solomon SD, Rayan ME, Come PC, Goldhaber SZ, Lee RT. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996;78:469-473. https://doi.org/10.1016/S0002-9149(96)00339-6
  7. Kukulski T, Voigt JU, Wilkenshoff UM, et al. A comparison of regional myocardial velocity information derived by pulsed and color Doppler techniques: an in vitro and in vivo study. Echocardiography 2000;17:639-651. https://doi.org/10.1046/j.1540-8175.2000.00639.x
  8. Yasui T, Tanabe N, Terada J, et al. Multidetector-row computed tomography management of acute pulmonary embolism. Circ J 2007;71:1948-1954. https://doi.org/10.1253/circj.71.1948
  9. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992;182:393-398. https://doi.org/10.1148/radiology.182.2.1732955
  10. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29:2276-2315. https://doi.org/10.1093/eurheartj/ehn310
  11. Shigeta A, Tanabe N, Shimizu H, et al. Gender differences in chronic thromboembolic pulmonary hypertension in Japan. Circ J 2008;72:2069-2074. https://doi.org/10.1253/circj.CJ-08-0377
  12. Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J 2000;15:440-448. https://doi.org/10.1034/j.1399-3003.2000.15.03.x
  13. Becattini C, Agnelli G, Pesavento R, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 2006;130:172-175. https://doi.org/10.1378/chest.130.1.172
  14. Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 1999;99:1325-1330. https://doi.org/10.1161/01.CIR.99.10.1325
  15. Lang I, Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:568-570. https://doi.org/10.1513/pats.200605-108LR
  16. Suntharalingam J, Goldsmith K, van Marion V, et al. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 2008;31:736-741. https://doi.org/10.1183/09031936.00055107
  17. Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 2013;41:462-468. https://doi.org/10.1183/09031936.00049312
  18. Galie N, Rubin Lj, Hoeper M, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 2008;371:2093-2100. https://doi.org/10.1016/S0140-6736(08)60919-8
  19. Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-158. https://doi.org/10.1378/chest.81.2.151

Cited by

  1. Right ventricular dysfunction is associated with the development of chronic thromboembolic pulmonary hypertension but not with mortality post-acute pulmonary embolism vol.98, pp.48, 2017, https://doi.org/10.1097/md.0000000000017953
  2. Chronic Thromboembolic Pulmonary Hypertension: Endovascular Treatment vol.49, pp.3, 2017, https://doi.org/10.4070/kcj.2018.0380
  3. Acute Pulmonary Thromboembolism: 14 Years of Surgical Experience vol.52, pp.2, 2017, https://doi.org/10.5090/kjtcs.2019.52.2.78
  4. Diagnosis of chronic thromboembolic pulmonary hypertension: A Canadian Thoracic Society clinical practice guideline update vol.3, pp.4, 2017, https://doi.org/10.1080/24745332.2019.1631663
  5. Technical efficiency, short-term clinical results and safety of a large-bore aspiration catheter in acute pulmonary embolism - A retrospective case study vol.37, pp.6, 2017, https://doi.org/10.4103/lungindia.lungindia_115_20
  6. Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism vol.16, pp.6, 2017, https://doi.org/10.20996/1819-6446-2020-12-09
  7. Current Endovascular Treatment Options in Acute Pulmonary Embolism vol.11, pp.None, 2017, https://doi.org/10.25259/jcis_229_2020